Brian Stal
Direktor/Vorstandsmitglied bei Imidomics, Inc.
Profil
Brian Stal is currently the Director at Imidomics, Inc. and the Vice President at DNS Capital LLC.
Previously, he worked as a Principal at The Pritzker Organization LLC from 2013 to 2022 and as a Board Member at Greycastle Holdings Ltd.
from 2014 to 2018.
Mr. Stal received his undergraduate degree from the University of Wisconsin in 2003 and his MBA from The University of Chicago Booth School of Business in 2008.
Aktive Positionen von Brian Stal
| Unternehmen | Position | Beginn |
|---|---|---|
DNS Capital LLC
 DNS Capital LLC Investment ManagersFinance DNS Capital LLC (DNS capital) is a venture capital firm founded in 2014. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01.07.2019 |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brian Stal
| Unternehmen | Position | Ende |
|---|---|---|
The Pritzker Organization LLC
 The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization LLC (TPO) is a private equity subsidiary of PRITZKER FAMILY founded in 2002 by Tom Pritzker. The firm is headquartered in New York. | Private Equity Investor | 31.12.2022 |
Greycastle Holdings Ltd.
 Greycastle Holdings Ltd. Financial ConglomeratesFinance Greycastle Holdings Ltd. engages in the operations as an investment holding company. The company is headquartered in Hamilton, Bermuda. | Direktor/Vorstandsmitglied | 30.04.2018 |
Ausbildung von Brian Stal
| University of Wisconsin | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization LLC (TPO) is a private equity subsidiary of PRITZKER FAMILY founded in 2002 by Tom Pritzker. The firm is headquartered in New York. | Finance |
Greycastle Holdings Ltd.
Greycastle Holdings Ltd. Financial ConglomeratesFinance Greycastle Holdings Ltd. engages in the operations as an investment holding company. The company is headquartered in Hamilton, Bermuda. | Finance |
DNS Capital LLC
DNS Capital LLC Investment ManagersFinance DNS Capital LLC (DNS capital) is a venture capital firm founded in 2014. The firm is headquartered in Chicago, Illinois. | Finance |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Health Technology |
